The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

[1]  S. Dollfus,et al.  Current developments and challenges in the assessment of negative symptoms , 2017, Schizophrenia Research.

[2]  A. Malla,et al.  Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample. , 2017, Psychiatric services.

[3]  J. van os,et al.  A critique of the “ultra‐high risk” and “transition” paradigm , 2017, World psychiatry : official journal of the World Psychiatric Association.

[4]  P. McGuire,et al.  Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders , 2017, European Psychiatry.

[5]  P. McGuire,et al.  Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. , 2016, Journal of affective disorders.

[6]  S. Wood,et al.  Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention , 2016, Schizophrenia Research.

[7]  P. McGorry,et al.  Why We Need a Transdiagnostic Staging Approach to Emerging Psychopathology, Early Diagnosis, and Treatment. , 2016, JAMA psychiatry.

[8]  Tae Young Lee,et al.  Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. , 2016, JAMA psychiatry.

[9]  A. Yung,et al.  Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra–high‐risk service , 2015, Early intervention in psychiatry.

[10]  A. Azbarova.  Personality Traits of Alcohol-dependent Women , 2015, European Psychiatry.

[11]  S. Wood,et al.  Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. , 2015, The American journal of psychiatry.

[12]  S. Borgwardt,et al.  Declining transition rates to psychosis: The role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome , 2014, Schizophrenia Research.

[13]  R. Kahn,et al.  Adolescents at ultra-high risk for psychosis: Long-term outcome of individuals who recover from their at-risk state , 2014, European Neuropsychopharmacology.

[14]  P. Cuijpers,et al.  Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups , 2013, Schizophrenia Research.

[15]  Hok Pan Yuen,et al.  Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. , 2013, JAMA psychiatry.

[16]  Tyrone D. Cannon,et al.  Whither the attenuated psychosis syndrome? , 2012, Schizophrenia bulletin.

[17]  G. Pell,et al.  Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. , 2012 .

[18]  D. Umbricht,et al.  Ultra high-risk state for psychosis and non-transition: A systematic review , 2011, Schizophrenia Research.

[19]  A. Yung,et al.  Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. , 2011, The Journal of clinical psychiatry.

[20]  A. Yung,et al.  Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis? , 2010, Schizophrenia Research.

[21]  A. Yung,et al.  Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Study Design and Baseline Characteristics , 2009, The Australian and New Zealand journal of psychiatry.

[22]  Larry J. Seidman,et al.  NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS , 2008, Schizophrenia Research.

[23]  C. Pantelis,et al.  Stress and HPA-axis functioning in young people at ultra high risk for psychosis. , 2007, Journal of psychiatric research.

[24]  A. Yung,et al.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? , 2007, Schizophrenia bulletin.

[25]  Johan C. Karremans,et al.  Procedural justice and the hedonic principle: how approach versus avoidance motivation influences the psychology of voice. , 2006, Journal of personality and social psychology.

[26]  I. Hickie,et al.  Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.

[27]  Hok Pan Yuen,et al.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features , 2004, Schizophrenia Research.

[28]  A. Yung,et al.  Mapping the onset of psychosis: The comprehensive assessment of at risk mental states (CAARMS) , 2003, Schizophrenia Research.

[29]  Hok Pan Yuen,et al.  Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.

[30]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[31]  A. Yung,et al.  The Initial Prodrome in Psychosis: Descriptive and Qualitative Aspects , 1996, The Australian and New Zealand journal of psychiatry.

[32]  Michael B. First,et al.  The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II): I. Description. , 1995 .

[33]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[34]  N C Andreasen,et al.  Negative symptoms in schizophrenia , 1982 .

[35]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[36]  I. Hickie,et al.  Effect of &ohgr;-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial , 2017, JAMA psychiatry.

[37]  T. McGlashan,et al.  The psychosis high-risk state: a comprehensive state-of-the-art review. , 2013, JAMA psychiatry.

[38]  S. Saha,et al.  Clinical correlates of olfactory hallucinations in schizophrenia , 2006 .

[39]  A. Yung,et al.  The prodromal phase of first-episode psychosis: past and current conceptualizations. , 1996, Schizophrenia bulletin.

[40]  J. Zubin.  Negative symptoms: are they indigenous to schizophrenia? , 1985, Schizophrenia bulletin.

[41]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.